Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2007
02/22/2007WO2007020786A1 Gene transfer method specific to trophectodermal cell
02/22/2007WO2007020708A1 Method of determining target base included in dna and allele-specific primer to be used in the method
02/22/2007WO2007020656A1 Pcr-based detection method for chlamydia treachomatis
02/22/2007WO2007020632A2 Methods and compositions for determining a level of biologically active serum paraoxonase
02/22/2007WO2007020457A2 Labelled modified guanine- containing nucleosides and nucleotides comprising a fluorophore attached to the base through a linking group comprising a polyethylene glycol spacing group and methods for their use
02/22/2007WO2007020444A1 Array comparative genomic hybridisation methods using linear amplification
02/22/2007WO2007020384A1 Analytical method and kit
02/22/2007WO2007020081A1 Composition and method for determination of ck19 expression
02/22/2007WO2007019899A2 Method for predicting the response to a treatment with a her dimerization inhibitor
02/22/2007WO2007019670A1 Method and nucleic acids for the improved treatment of breast cancers
02/22/2007WO2007019619A1 Chromatographic analysis of nucleic acids
02/22/2007WO2007019603A1 A method for detecting the interaction of a polypeptide of interest with a target nucleotide sequence
02/22/2007WO2007019595A2 Method for the detection of an external administration of human growth hormone (hgh)
02/22/2007WO2007001264A3 Method of making recombinant human antibodies for use in biosensor technology
02/22/2007WO2006131892A3 Amplification of nucleic acids with magnetic detection
02/22/2007WO2006131562A3 Diagnostic and therapeutic target cdc2l6 gene and proteins for neurodegenerative diseases
02/22/2007WO2006122554A3 Enzyme sensor with a cover membrane layer covered by a hydrophilic polymer
02/22/2007WO2006119439A3 Compositions and methods for the analysis of degraded nucleic acids
02/22/2007WO2006113728A3 Inhibiting biofilm formation
02/22/2007WO2006113706A3 Increased sensitivity of nucleic acid-based detection of organisms by fractionation of target genomes
02/22/2007WO2006105213A3 Methods and kits for detection of chromosome aneuploidy by high performance liquid chromatography with post-column fluorescence detection
02/22/2007WO2006104991A3 Kits and methods for assessing antioxidant requirement of a human
02/22/2007WO2006104474A3 A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
02/22/2007WO2006097339A3 Method and materials therefor
02/22/2007WO2006091899A3 Epidermal growth factor receptor mutations
02/22/2007WO2006086737A3 Mir-155 assay
02/22/2007WO2006086502A3 Key probe compositions and methods for polynucleotide detection
02/22/2007WO2006085964A3 Log-linear amplification
02/22/2007WO2006084133A3 Methods for dosing l-thyroxine
02/22/2007WO2006083671A3 Bacterial glycolipid activation of cd1d-restricted nkt cells
02/22/2007WO2006081380A3 Handheld raman body fluid analyzer
02/22/2007WO2006059228A3 Polypeptides involved in candida biofilm formation and uses thereof
02/22/2007WO2006047673A3 Mammalian genes involved in infection
02/22/2007WO2006037059A3 Point-of-care mass spectrometer system
02/22/2007WO2006007207A3 Methods and devices for nucleic acid sequence determination
02/22/2007WO2005089518A3 Uch-l1 expression and cancer therapy
02/22/2007WO2005089148A3 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers
02/22/2007WO2005042725A3 Liver cancer biomarkers
02/22/2007WO2005042719A3 Methods for treating and preventing ischemia-reperfusion injury using rna interfering agents
02/22/2007WO2004098491A3 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES
02/22/2007WO2004074436A3 Methods of use of a gpcr in the diagnosis and treatment of colon and lung cancer
02/22/2007WO2004048543A3 Methods and compositions for controlling valency of phage display
02/22/2007WO2003073991A3 Methods to increase or decrease bone density
02/22/2007US20070044176 Nitrate transport components
02/22/2007US20070044172 use of nucleotide sequences in the genetic-engineering of plants to display enhanced nitrogen assimilatory and utilization capacities, grow larger, more efficiently or rapidly, and/or have enriched nitrogen contents in vegetative and/or reproductive plant parts and/or increased biomass
02/22/2007US20070044171 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
02/22/2007US20070044170 Rna virus-derived plant expression system
02/22/2007US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals
02/22/2007US20070044164 Methods for producing microRNAs
02/22/2007US20070044163 Interferon gamma-like protein
02/22/2007US20070043694 System and method for data analysis, manipulation, and visualization
02/22/2007US20070043517 Techniques for identifying, confirming, mapping, and categorizing polymers
02/22/2007US20070043514 Methods, software arrangements, storage media, and systems for genotyping or haplotyping polymorphic genetic loci or strain identification
02/22/2007US20070043289 Method and Apparatus Including Use of Metalloporphyrins for Subsequent Optimization of Radiosurgery and Radiotherapy
02/22/2007US20070043283 Method and Apparatus for Non-Invasive Monitoring of Blood Substances Using Self-Sampled Tears
02/22/2007US20070043209 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
02/22/2007US20070043002 Aldolase-inhibiting aromatic compounds
02/22/2007US20070042983 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
02/22/2007US20070042982 Bioinformatically detectable group of novel regulatory bacterial and bacterial associated oligonucleotides and uses thereof
02/22/2007US20070042981 Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
02/22/2007US20070042978 Nf-hev compositions and methods of use
02/22/2007US20070042977 Vaccine
02/22/2007US20070042948 Vav inhibition in graft rejection
02/22/2007US20070042945 Nouvelles compositions et methods de traitement du psoriasis
02/22/2007US20070042576 Stable, water-soluble quantum dot, method of preparation and conjugates thereof
02/22/2007US20070042483 Methods and device for adhesive control of internal cell organisation
02/22/2007US20070042480 Adding biooxidizable material into reactor having an anode and a cathode and containing anodophilic bacteria in aqueous medium; applying a potential between anode and cathode and collecting hydrogen gas; may be intermittently switched to an electric power generation stage; biocatalysis; biofuel cells
02/22/2007US20070042468 Interferon-like protein zcyto21
02/22/2007US20070042454 Device and method of detecting streptococcal mutans
02/22/2007US20070042453 High throughput screening method for antimicrobial formulations
02/22/2007US20070042452 Detection of plasma ACE2
02/22/2007US20070042451 Glycine decarboxylase complex as a herbicidal target
02/22/2007US20070042450 Multi-transduction mechanism based microfluidic analyte sensors
02/22/2007US20070042449 Qualitative and semi-quantitative detection of a ligand in a sample of a medium to be tested; color reaction obtained by catalysis of a non-coupled or coupled chromogenic compound by a peroxidase enzyme in the presence of hydrogen peroxide produced by the activated apoenzyme; veterinary medicine
02/22/2007US20070042448 Use of enzymes from Helicobacter pylori as therapeutical targets
02/22/2007US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
02/22/2007US20070042435 Assays for sensory modulators using a sensory cell specific G-protein beta subunit
02/22/2007US20070042431 Methods for reducing complexity of a sample using small epitope antibodies
02/22/2007US20070042424 Distinguishing target adiponectin multimer from the other adiponectin multimers by using a protease and/or an antibody; accurately evaluate the relationship between a disease and adiponectin
02/22/2007US20070042422 Used for the rapid identification of frequently occurring bacteria, viruses and fungi
02/22/2007US20070042421 Method of identifying nucleic acids
02/22/2007US20070042420 Liver tumor marker sequences
02/22/2007US20070042419 genetic screening; multiplex detection; rapid single assay format
02/22/2007US20070042418 Therapeutic modulation of the fas pathway
02/22/2007US20070042417 Use of a nucleic acid probe to detect Zven, a human protein that may inhibit Wnt, and is an agent that stimulates gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis
02/22/2007US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule
02/22/2007US20070042415 Anti-fused antibodies
02/22/2007US20070042414 Retentate chromatography and protein chip arrays with applications in biology and medicine
02/22/2007US20070042413 Platelet-derived growth factor D, DNA coding therefor, and uses thereof
02/22/2007US20070042412 Detection of biologically active compounds
02/22/2007US20070042411 Multiplexed PCR assay for detection of bovine spongiform encephalopathy (BSE)-associated bovine prion protein gene (PRNP) polymorphisms
02/22/2007US20070042410 Screening method for genes of brewing yeast
02/22/2007US20070042409 Mammalian obestatin receptors
02/22/2007US20070042408 Nucleotide sequence for assessing transmissible spongiform encephalopathies
02/22/2007US20070042407 Modified nucleosides and nucleotides and uses thereof
02/22/2007US20070042406 Diffusion mediated clean-up of a target carrier fluid
02/22/2007US20070042405 Enhanced diagnostic multimarker serological profiling
02/22/2007US20070042404 Compositions and method for detecting endonuclease activity
02/22/2007US20070042403 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases
02/22/2007US20070042402 Method for Predicting Human Longevity